NCT04249544View on ClinicalTrials.gov

Social Decision Making in Parkinson's Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

December 3, 2019

Primary Completion Date

June 1, 2022

Study Completion Date

September 1, 2022

Conditions
Parkinson Disease
Interventions
DRUG

Pramipexole

1mg of pramipexole

DRUG

Placebo

1mg equivalent of placebo

Trial Locations (1)

37212

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

Vanderbilt University Medical Center

OTHER

NCT04249544 - Social Decision Making in Parkinson's Disease | Biotech Hunter | Biotech Hunter